Reagent for damaging vestibular hair cells and construction method of vestibular hair cell damage model
By using reagents and photoirradiation technology of dihydrophane e6 and PEG-PLGA, a vestibular hair cell injury model was constructed, which solved the safety risks and hearing loss of vestibular hair cell injury treatment in the prior art, and achieved without affecting hearing inhibiting vestibular function under the premise of the premise of this, providing support for scientific research and virtual reality technology.
Patent Information
- Application Number
- CN202411168373.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-23
AI Technical Summary
The prior art often has great safety risks and hearing loss risks when treating vestibular hair cell damage, and there is a lack of effective reagents for damaging vestibular hair cells to build vestibular hair cell damage models.
A reagent for damaging vestibular hair cells, including solvents and dihydrophane e6 and PEG-PLGA added to the solvent, is provided, and a photosensitive agent is activated by photoirradiation to prepare a vestibular hair cell damage model, significantly inhibiting vestibular function.
Without affecting hearing function, it significantly inhibits vestibular function, providing ideas for scientific research such as balancing perception, auditory and neurology, and improving the realism and interactivity of virtual reality technology.
Smart Images

Figure CN119020286A_ABST
Abstract
Description
Technical Field
[0001] The present application belongs to the field of neuroscience, and specifically relates to a reagent for damaging vestibular hair cells and a method for constructing a vestibular hair cell damage model. Background Art
[0002] The maintenance of human balance depends on the sensory information input from the vestibular system, proprioceptive system and visual system, as well as the complex connection and integration between the peripheral and central nervous systems. In a static state, the vestibular receptors on both sides continuously send equal nerve impulses to the vestibular nuclei on the same side symmetrically. At the same time, the information from vision and proprioception is also transmitted to the central nervous system. Under a series of complex neural reflexes, the visual stability and postural balance of the human body are maintained. When any part of the vestibular system and its connection with the central nervous system is affected by physiological stimulation or pathological factors, the bilateral symmetry or balance of this information transmission may be destroyed. The result will be manifested as balance disorder objectively and vertigo subjectively, that is, the body produces a kind of movement or position illusion due to spatial positioning disorder.
[0003] Among the synergistic effects of vision, proprioception, and the vestibular system, the vestibular system is the most important for maintaining body posture balance. Clinically, vertigo is often divided into vestibular vertigo and non-vestibular vertigo. The former includes not only central vestibular vertigo such as brainstem lesions, cerebellar diseases, and cerebral diseases, but also peripheral vestibular vertigo such as otogenic vertigo and neurogenic vertigo. Among them, diseases related to otogenic vertigo caused by inner ear lesions include Meniere's disease, labyrinthitis, inner ear otolith lesions, etc. These diseases are usually related to poor vestibular function inhibition, and existing technologies to solve this problem are often accompanied by great safety risks.
[0004] Taking the intermittent treatment of Meniere's disease as an example, according to the "Guidelines for the Diagnosis and Treatment of Meniere's Disease (2017)", three semicircular canal occlusion and intratympanic injection of gentamicin can be used. The former requires a doctor to perform a surgical operation to cut off and fill the semicircular canals to block the flow of endolymph, which can effectively control the vertigo attacks of Meniere's disease, but this operation is prone to local infection, leading to sequelae such as lymph outflow and hearing loss. The latter is to inject the ototoxic drug gentamicin into the inner ear labyrinth through the tympanic cavity to remove the unilateral chemical labyrinth. This method can also effectively control the vertigo symptoms of most patients. However, intratympanic injection of gentamicin will damage the cochlear hair cells while killing the vestibular hair cells, resulting in hearing loss in patients. Therefore, it is stipulated that patients must be fully informed of the risk of hearing loss before treatment.
[0005] In addition to clinical practice, inhibiting vestibular function has also been a hot topic in scientific research fields such as balance, hearing, and neurology, which helps people better understand the physiological and pathological mechanisms of balance perception and balance disorders, the generation and transmission mechanism of auditory signals, the activity of neurons, and the release of neurotransmitters. At the same time, with the development of virtual reality and augmented reality technology, the vestibular system is also used to develop more realistic virtual reality and augmented reality experiences. By simulating the vestibular system, the human body's balance perception and action response can be better simulated, thereby improving the realism and interactivity of virtual reality and augmented reality technology.
[0006] However, there is currently no reagent that damages vestibular hair cells that can be used to construct a vestibular hair cell injury model. Summary of the invention
[0007] Based on this, an embodiment of the present application provides a reagent for damaging vestibular hair cells, which is used for constructing a vestibular hair cell damage model.
[0008] On the one hand, the present application provides a reagent for damaging vestibular hair cells, including a solvent and chlorin e6 and PEG-PLGA added to the solvent;
[0009] The final concentration of the dihydrochlorin e6 in the solvent is 0.01 mg / mL to 0.02 mg / mL; the final concentration of the PEG-PLGA in the solvent is 0.02 mg / mL to 0.08 mg / mL.
[0010] In one embodiment, the solvent comprises tetrahydrofuran.
[0011] On the other hand, the present application provides a method for constructing a vestibular hair cell injury model, comprising:
[0012] Mixing a reagent for damaging vestibular hair cells with vestibular hair cells to be cultured to prepare a culture;
[0013] irradiating the culture with light to obtain a vestibular hair cell injury model;
[0014] The reagent for damaging vestibular hair cells includes a pre-made reagent or a ready-made reagent, and the reagent meets the above definition of the reagent for damaging vestibular hair cells.
[0015] In one embodiment, the step of ultrasonically oscillating the reagent for damaging vestibular hair cells is further included before mixing.
[0016] In one embodiment, the vestibular hair cells are semicircular canal hair cells.
[0017] In one embodiment, the light irradiation is performed with a power of 0.4 mW to 0.6 mW for 2 min to 10 min.
[0018] In one embodiment, the light irradiation includes irradiation with light in the near-infrared region or light in the visible light region.
[0019] In one embodiment, the wavelength of the light in the near-infrared region is 700nm~1000nm.
[0020] In one embodiment, the wavelength of the light in the visible light region is 280nm~680nm.
[0021] The present application also provides a vestibular hair cell damage model constructed by the above-mentioned method for constructing a vestibular hair cell damage model.
[0022] The present application provides a reagent for damaging vestibular hair cells, including a solvent and a dihydrochlorin e6 added to the solvent at a final concentration of 0.01 mg / mL to 0.02 mg / mL and a PEG-PLGA at a final concentration of 0.02 mg / mL to 0.08 mg / mL. Among them, dihydrochlorin e6, as a naturally occurring photosensitizer, has strong absorption capacity in the near-infrared region and the visible light region, and has good fluorescence characteristics. PEG-PLGA is a biodegradable polymer material with high biocompatibility. The use of this substance to prepare nanoparticles can increase the water solubility of the nanoparticles and reduce the decomposition and aggregation of the reagent, thereby increasing the stability of the reagent. The vestibular hair cell injury model constructed in this way can damage the vestibular receptors in the horizontal semicircular canal without affecting the hearing function, significantly inhibiting the vestibular function, and providing ideas for vestibular research in scientific research fields such as balance, hearing and neurology. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] In order to more clearly illustrate the technical solutions in the embodiments of the present application and to more completely understand the present application and its beneficial effects, the following is a brief introduction to the drawings required for the description of the embodiments. Obviously, the drawings described below are only some embodiments of the present application, and those skilled in the art can obtain other drawings based on these drawings without creative work.
[0024] Figure 1 A flowchart of a method for inducing controllable damage to vestibular hair cells in vitro in an embodiment;
[0025] Figure 2 is a morphology diagram of Ce6 NPs in an embodiment; wherein, Figure 2 a in the figure is a photo of Ce6 NPs aqueous solution. Figure 2 b is a transmission electron microscope image;
[0026] Figure 3 is a graph showing the survival rate of HEI-OC1 cells in one embodiment;
[0027] Figure 4 is a graph showing the number of surviving hair cells in cochlear explants in one embodiment;
[0028] Figure 5 This is a graph showing the test results of the horizontal angle vestibular-ocular reflex of mice in the control group and the photodynamic therapy group in an embodiment; wherein, Figure 5 a in Figure 5 b in the figure respectively represents the ability of the left and right eyes of the mouse to follow the rotating head;
[0029] Figure 6 This is a graph showing the test results of the horizontal angle vestibular ocular reflex of mice in the photodynamic therapy group after 2 minutes of illumination in one embodiment; wherein: Figure 6 a in Figure 6 b in the figure respectively represents the contralateral eye movement and ipsilateral eye movement of mice;
[0030] Figure 7 This is a graph showing the test results of the horizontal angle vestibular-ocular reflex of mice in the photodynamic therapy group treated with light for 2 minutes and 10 minutes in one embodiment; wherein, Figure 7 a in Figure 7 b in the figure respectively represents the contralateral eye movement and ipsilateral eye movement of mice;
[0031] Figure 8 is a result diagram of a non-vertical axis rotation test in one embodiment, wherein Figure 8 a in Figure 8 b in the figure respectively represents the contralateral eye movement and the ipsilateral eye movement;
[0032] Fig. 9 is a diagram of the auditory brainstem response test results in an embodiment; wherein, Fig. 9 a~ Fig. 9 The d in the figure represent the conditions before light irradiation, before injection of reagents, before photodynamic therapy, and after photodynamic therapy, respectively;
[0033] Fig.10 is a fluorescence microscope image of the ampulla ridge of the horizontal semicircular canal in one embodiment;
[0034] Fig.11 is a fluorescence microscope image of the otolith utricle in one embodiment;
[0035] Fig.12 is a statistical diagram of the number of hair cells in the otolith utricle in an embodiment; wherein, Fig.12 a in Fig.12The b in the figure respectively represents the situation of the surrounding area and the central area;
[0036] Fig.13 is a fluorescence microscopy image of the cochlear basilar membrane in one embodiment;
[0037] Fig.14 A statistical diagram of the number of hair cells at the basilar membrane of the cochlea in one embodiment. DETAILED DESCRIPTION
[0038] Below in conjunction with embodiment and example, the application is further described in detail.It should be understood that these embodiments and examples are only used to illustrate the application and are not used to limit the scope of the application, and the purpose of providing these embodiments and examples is to make the understanding of the disclosure of the application more thorough and comprehensive.It should also be understood that the application can be implemented in many different forms, is not limited to the embodiment and example described herein, and those skilled in the art can make various changes or modifications without violating the connotation of the application, and the equivalent form obtained also falls within the protection scope of the application.In addition, in the description below, a large number of specific details are given in order to provide a more comprehensive understanding of the application, and it should be understood that the application can be implemented without one or more of these details.
[0039] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application belongs.
[0041] All documents mentioned in this application are cited as references in this application, just as each document is cited as reference separately. Unless they conflict with the application purpose and / or technical solution of this application, the cited documents involved in this application are cited with all contents and all purposes. When the cited documents are involved in this application, the definitions of relevant technical features, terms, nouns, phrases, etc. in the cited documents are also cited. When the cited documents are involved in this application, the examples and preferred methods of the cited relevant technical features can also be incorporated into this application as references, but are limited to the implementation of this application. It should be understood that when the cited content conflicts with the description in this application, the present application shall prevail or be modified adaptively according to the description of this application.
[0042] The structure of the human ear can be divided into three parts: the outer ear, the middle ear and the inner ear. The basic function of the outer ear is to collect sound waves and transmit them to the middle ear. The middle ear converts sound energy into mechanical energy to transmit to the inner ear. The inner ear converts mechanical energy into neural electrical impulses and sends them to the brain. Figure 1As shown in the figure, the inner ear is also called the labyrinth, which includes the cochlea, vestibular labyrinth, and various nerves. Among them, the cochlea is an important structure for transmitting sound, which is a spiral tube filled with fluid and covered with sensory cells. When sound is transmitted to the inner ear, the fluid in the cochlea flows and drives the sensory cells, that is, the cilia on the hair cells, to swing, generating a potential difference, which is then transmitted to the brain under the action of the auditory nerve. When the cochlear hair cells are damaged, the transmission of this electrical signal is hindered, resulting in hearing loss and other phenomena. The vestibular labyrinth is an important part of the human body's balance system and is composed of otoliths and semicircular canals. The saccule and utricle are used as otoliths to sense linear acceleration, and the three semicircular canals - the horizontal semicircular canal, the anterior vertical semicircular canal, and the posterior vertical semicircular canal - are used to sense head rotation.
[0043] The present application provides a method for inducing controllable damage to vestibular hair cells in vitro. By controlling the damage range of vestibular hair cells, vestibular function can be inhibited, surgical side effects can be reduced, and the functions of adjacent otolith organs and cochlear organs can be protected, thereby effectively avoiding hearing damage. This provides ideas for vestibular research in scientific research fields such as balance, hearing, and neurology, and also provides guidance for improving the realism and interactivity in virtual reality technology.
[0044] It is to be understood that the "drugs" mentioned below are agents used to damage vestibular hair cells, which have the same ingredients and may be equivalent in effect.
[0045] like Figure 1 As shown, the method for inducing controllable damage to vestibular hair cells in vitro includes contacting a drug containing a photosensitizer with vestibular hair cells and irradiating the drug with light. When light irradiates the horizontal semicircular canal, the principle of photodynamic therapy is used to activate the photosensitizer nanomedicine, thereby generating reactive oxygen species at the location, damaging the vestibular receptors therein - hair cells, thereby inhibiting vestibular function.
[0046] Photodynamic therapy (PDT) is a relatively new non-invasive treatment method that relies on a light source of a specific wavelength to irradiate and activate photosensitizers in tissues to produce reactive oxygen species such as singlet oxygen that are biologically toxic. The presence of this reactive oxygen species will disrupt the dynamic balance of singlet oxygen production and clearance in cells under normal circumstances, causing a series of physiological reactions, leading to the death of tumor cells, virus-infected cells, and other overproliferating cells.
[0047] On the one hand, the present application provides a reagent for damaging vestibular hair cells, comprising a solvent and dihydrochlorin e6 and PEG-PLGA added to the solvent.
[0048] Among them, the final concentration of dihydrochlorin e6 in the solvent is 0.01 mg / mL~0.02 mg / mL, and the final concentration of PEG-PLGA in the solvent is 0.02 mg / mL~0.08 mg / mL. For example, the final concentration of dihydrochlorin e6 in the solvent is 0.01 mg / mL, 0.012 mg / mL, 0.014 mg / mL, 0.016 mg / mL, 0.018 mg / mL, 0.02 mg / mL, and the final concentration of PEG-PLGA in the solvent is 0.02 mg / mL, 0.03 mg / mL, 0.04 mg / mL, 0.05 mg / mL, 0.06 mg / mL, 0.07 mg / mL, 0.08 mg / mL.
[0049] In one specific example, the solvent includes tetrahydrofuran.
[0050] In one specific example, the vestibular hair cells are semicircular canal hair cells.
[0051] The present application also provides a method for constructing a vestibular hair cell injury model, comprising mixing a reagent for damaging vestibular hair cells with vestibular hair cells to be cultured, preparing a culture, and then irradiating the culture with light to obtain a vestibular hair cell injury model;
[0052] The reagents for damaging vestibular hair cells include pre-made reagents and ready-made reagents, and the reagents meet the definition of reagents for damaging vestibular hair cells.
[0053] Optionally, the light irradiation is performed with a power of 0.4 mW to 0.6 mW for 2 min to 10 min, for example, 0.4 mW, 0.5 mW, 0.6 mW for 2 min, 3 min, 4 min, 5 min, 6 min, 7 min, 8 min, 9 min, 10 min.
[0054] In a specific example, the light irradiation includes using light in a near infrared region or light in a visible region.
[0055] Optionally, the wavelength of the light in the near-infrared region is 700 nm to 1000 nm, and the wavelength of the light in the visible light region is 280 nm to 680 nm.
[0056] The present application also provides a vestibular hair cell injury model constructed by a method for constructing a vestibular hair cell injury model.
[0057] The embodiments of the present application will be described in detail below in conjunction with examples. It should be understood that these examples are only used to illustrate the present application and are not intended to limit the scope of the present application. The experimental methods for which specific conditions are not specified in the following examples are preferably referred to the guidance provided in the present application, and can also be based on the experimental manual or normal conditions in this area, can also be based on the conditions recommended by the manufacturer, or refer to experimental methods known in the art.
[0058] In the following specific embodiments, the measured parameters of raw material components may have slight deviations within the range of weighing accuracy unless otherwise specified. For temperature and time parameters, acceptable deviations caused by instrument test accuracy or operation accuracy are allowed.
[0059] Example 1
[0060] 1. Preparation of reagents for damaging vestibular hair cells
[0061] The raw materials for preparing Ce6 NPs in this embodiment include chlorin e6 (Ce6) and poly (ethylene glycol) methyl ether block-poly (lactide-co-glycolide) (PEG-PLGA). Among them, Chlorin e6, as a naturally occurring photosensitizer, has strong absorption capacity in the near-infrared region and the visible light region, and has good fluorescence properties. PEG-PLGA is a biodegradable polymer material with high biocompatibility. The use of this material to prepare nanoparticles can increase the water solubility of nanoparticles and reduce the decomposition and aggregation of drugs, thereby increasing the stability of the drugs. In addition, the addition of PEG-PLGA can also reduce the immunogenicity of nanoparticles, thereby increasing the bioavailability of nanoparticles in the body. At the same time, the release rate and duration of the drug can be controlled by adjusting the proportion and molecular structure of the PEG-PLGA polymer, so that the drug is released into the target tissue in a more lasting manner, thereby improving the therapeutic effect.
[0062] That is, the addition of PEG-PLGA can improve the stability and bioavailability of nanoparticles and control the release rate of drugs, thus having greater therapeutic potential in applications such as photodynamic therapy.
[0063] The preparation steps of Ce6 NPs encapsulating Ce6 are as follows: First, PEG-PLGA and Chlorin e6 are dissolved in tetrahydrofuran solvent to a final concentration of 0.45 mg / mL and 0.15 mg / mL, respectively. After sufficient dissolution, 1 mL of the mixed solution is taken and quickly injected into 10 mL of deionized water under ultrasonic vibration conditions, that is, the concentration of Ce6 is 0.01 mg / mL~0.02 mg / mL. After ultrasonic vibration for 2 minutes, a clear and transparent Ce6 NPs aqueous solution can be obtained.
[0064] result: Figure 2 The morphology of Ce6 NPs is shown. From its photos and transmission electron microscopy images, it can be seen that Ce6 NPs are well dispersed in the aqueous solution framework and are very small in size, concentrated in 20nm~30nm, and also contain more effective Ce6 photosensitizers. If the concentration of Ce6 and PEG-PLGA is too high, it will lead to the aggregation of nanomedicines or the over-size of nanomedicines. At the same time, in addition to deionized water, other pharmaceutical waters that meet the quality standards and relevant requirements of the "Pharmacopoeia of the People's Republic of China" can also be used, such as purified water, water for injection, etc.
[0065] 2. Test verification:
[0066] 1. In vitro testing of mouse cochlear hair cells
[0067] First, mouse cochlear hair cells HEI-OC1 were cultured in a 96-well plate with a cell density of 3000 cells / well. Then, the Ce6 NPs aqueous solution prepared above was added to the cell well plate at a concentration of 3 μg / mL, 5 μg / mL, and 10 μg / mL. As a control, the cell well plate was left with a growth environment without Ce6 NPs aqueous solution. Subsequently, the cells were cultured under an irradiance of 50 mW / cm 2 The cells were irradiated with a LED light source with a wavelength of 650 nm for 10 min. As a control, Ce6 NPs with different concentrations were set up in groups without light radiation. Finally, the cells were placed in an incubator for culture, and the cell survival rate was detected after 24 h.
[0068] result: Figure 3 The survival status of HEI-OC1 cells is shown, where the horizontal axis is the Ce6 NPs concentration and the vertical axis is the cell survival rate. The black column indicates that Ce6 NPs were added for culture but no light was irradiated, and the gray column indicates that Ce6 NPs were added for culture and light irradiated.
[0069] It can be seen that the addition of Ce6 NPs to the cell wells had a negative impact on the growth of HEI-OC1, and the cell survival rate decreased slightly with the increase of Ce6 NPs concentration.
[0070] In addition, irradiation of HEI-OC1 cultured without adding photosensitizers also reduced cell survival, but not significantly. However, the cell survival rate of the group treated with photodynamic therapy, that is, adding photosensitizer Ce6 NPs and irradiating with light, decreased significantly compared with other groups. Moreover, as the concentration of photosensitizer increased, the degree of cell survival decreased more significantly. This is largely related to the reactive oxygen species produced by Ce6 NPs stimulated by light, and a series of physiological reactions triggered by this substance led to a decrease in cell survival. Therefore, the use of photodynamic therapy can cause damage to mouse cochlear hair cells HEI-OC1.
[0071] 2. In vitro testing of cochlear basilar membrane cells
[0072] Mice were dissected 3-4 days after birth, and their cochlear basal membranes were taken for in vitro tissue culture. Subsequently, the Ce6 NPs solution prepared above was added to the culture environment at a concentration of 5 μg / mL, and the irradiance was 50 mW / cm 2 , and irradiated for 10 minutes under an LED light source with a wavelength of 650nm. As a control, groups without adding Ce6 NPs solution and no illumination, without adding Ce6 NPs solution and illumination, and with adding Ce6 NPs solution and no illumination were set up. Finally, the cells were placed in an incubator for culture, and the cells were fixed and immunofluorescence stained after 6 hours to count the survival rate of hair cells.
[0073] result: Figure 4 The survival of cochlear basement membrane cells is shown, where the horizontal axis is the culture conditions of different groups, and the vertical axis is the number of hair cells in 100μm units. It can be seen that there is almost no difference in the number of surviving hair cells in the cochlear explants of the groups that did not undergo photodynamic therapy, but the number of cells in the group that irradiated cells with light after adding photosensitizers decreased significantly compared with the other three groups, and the difference was significant. Therefore, the application of photodynamic therapy can damage the cochlear basement membrane cells of mice.
[0074] 3. Horizontal angle vestibular ocular reflex test
[0075] (1) After assessing the vestibular and cochlear function of mice under normal healthy conditions, surgical procedures were performed on the mice's ears: a small hole was first drilled to partially expose the horizontal semicircular canal, and then the Ce6 NPs prepared above were microinjected into the inner ear labyrinth at a concentration of 15 μg / mL, with an injection volume of 50 μL and an injection time of 10 min. Subsequently, an optical fiber with a power of 0.5 mW and a wavelength of 650 nm was used to target the location of the small hole and irradiate for 2 min and 10 min to excite the photosensitizer drug. Finally, the small hole was sealed with tissue glue, and the mice recovered for a week after the surgical wound was sutured.
[0076] (2) Based on step (1), the horizontal vestibular-ocular reflex test (VOR test) was performed on the control mice under normal health conditions, the photodynamic therapy group with 2 minutes of light exposure, and the photodynamic therapy group with 10 minutes of light exposure. Specifically, the awake mice were fixed on the experimental turntable, and two infrared motion cameras located in front of the mice were used to respectively record the eye movement videos of the mice under the most flat rotation stimulation. The rotation frequency of the turntable was 0.5Hz, 0.8Hz, 1.6Hz, and 3.2Hz, and the rotation angular velocity was 40° / s. Then, the mouse eye movement video was processed with a specific analysis program and software to obtain the eye movement related parameters, and the maximum amplitude of the pupil movement was selected as the reference to evaluate the vestibular function of the mice.
[0077] result: Figure 5 The results show that the eyes of mice in the control group and the photodynamic therapy group can follow the rotating head in the VOR test. Figure 5 a and Figure 5 The b in the figure represents the situation of the left eye and the right eye respectively. The horizontal axis is the rotation frequency of the turntable, and the vertical axis is the Gain value, that is, the increased eye movement amplitude.
[0078] It can be seen that the Gain value of the control group mice that did not receive photodynamic therapy remained roughly around 1, indicating that when the head rotated, the eyeballs of this group of mice were able to follow the rotation and keep their gaze unchanged, that is, the eyeballs almost completely followed the head rotation. The Gain values of the mice that underwent local vestibular photodynamic damage were far less than 1, and the P values were all less than 0.01 compared with the control group, indicating that the binocular eye movement amplitude of this group of mice was significantly reduced, that is, the eyeballs moved less than the head rotation.
[0079] Figure 6 The results show that the eyeballs of mice in the photodynamic therapy group can follow the rotating head in the VOR test after 2 minutes of light exposure. Figure 6 a and Figure 6 The b in the figure represents the contralateral eye movement and the ipsilateral eye movement respectively. The horizontal axis is the rotation frequency of the turntable, and the vertical axis is the Gain value, that is, the increased eye movement amplitude.
[0080] It can be seen that after local vestibular photodynamic damage, the VOR eye movement part of the mice in the 2-min light exposure group showed a significant decrease one week later, indicating that the function of their horizontal semicircular canal was affected.
[0081] Figure 7 The results show that the eyeballs of mice in the photodynamic therapy group with 2 minutes of light exposure and 10 minutes of light exposure can follow the rotating head in the VOR test. Figure 7 a and Figure 7The b in the figure represents the contralateral eye movement and the ipsilateral eye movement respectively. The horizontal axis is the rotation frequency of the turntable, and the vertical axis is the Gain value, that is, the increased eye movement amplitude.
[0082] It can be seen that the decrease in eye movement performance of the vestibular ocular reflex of mice in the 10-min illumination group was significantly greater than that in the 2-min illumination group, which indicates that the decline in horizontal semicircular canal function increases with the extension of illumination time. However, at the same time, the light irradiation time should not be too long, and the power of the irradiated light should not be too strong, so as not to produce a high thermal effect and cause excessive local temperature of the tissue. In addition, the surgical method involved in this protocol has a small wound and no postoperative side effects such as infection occurred.
[0083] 4. Non-vertical axis rotation test
[0084] The mice obtained in step (1) of the horizontal vestibular ocular reflex test were subjected to an off-vertical axis rotation test (OVAR test). Specifically, the VOR experimental device was tilted 17°, and the awake mice were fixed on the experimental turntable. Two infrared motion cameras located in front of the mice were used to take videos of the mice's eye movements, where the turntable's rotation angular velocity was 30° / s, 50° / s, and 80° / s. Then, the mouse eye movement videos were processed using a specific analysis program and software to obtain parameters related to eye movement, and the maximum amplitude of the pupil movement in the Y-axis direction was selected as a reference to evaluate the vestibular function of the mice.
[0085] result: Figure 8 The OVAR test showed the ability of the eyeballs of mice in the photodynamic therapy group to follow the rotating head after 2 minutes of light exposure. Figure 8 a in Figure 8 The b in the figure represents the contralateral eye movement and the ipsilateral eye movement respectively, the abscissa is the angular velocity of the turntable, and the ordinate is the amplitude of the pupil.
[0086] It can be seen that there was no significant decrease in the OVAR eye movement of mice in the photodynamic therapy group with 2 minutes of illumination, indicating that there was no significant inhibition of their otolith function. Combined with the significant decrease in the VOR eye movement of this group of mice, it can be seen that 2 minutes of photodynamic therapy for mice will affect the function of the horizontal semicircular canal, but will not affect the normal function of their otolith function. In addition, after local vestibular photodynamic damage, the eye movements presented by the VOR and OVAR tests of mice in the 10 minutes illumination group were significantly reduced, indicating that the damage to the horizontal semicircular canal and otolith function was suppressed.
[0087] Combined with the above results, when the photodynamic intensity is strong, the damage covers the otolith organs and the horizontal semicircular canal; when the degree of photodynamic damage is weakened, the damage range can be reduced to the horizontal semicircular canal, and the otolith organs function normally. Therefore, this method has flexible controllability, which is conducive to vestibular research in scientific research fields such as balance, hearing and neurology. For example, by adjusting the laser irradiation time to control the damage range of photodynamic therapy, the influence of different vestibular organs on experimental results can be studied, thereby ensuring that the research results can be repeated and verified, helping researchers to better interpret the experimental results, derive relevant theories, and also help to develop more realistic virtual reality and augmented reality experiences.
[0088] 5. Auditory brainstem response test
[0089] The mice obtained in step (1) of the horizontal angle vestibular ocular reflex test were subjected to an auditory brainstem response (ABR) test. First, the mice were placed in an experimental box, and electrodes were inserted under the skin of the top of the head, thighs, and cheeks to detect the electrical signals of the mice's auditory response. The speakers played sound stimuli for testing, where the pure tone intensity was 90dB~10dB, and the sound frequencies were 4KHz, 8KHz, 12KHz, 16KHz, 24KHz, and 32KHz. During the test, the mice's auditory response electrical signals were recorded, and the mice's electrical signals were amplified by an amplifier so that the signals could be recorded and analyzed using a computer or other equipment. Finally, data analysis was performed and the hearing threshold of the mice was recorded.
[0090] result: Fig. 9 The auditory thresholds in the auditory brainstem response test of mice are shown. Fig. 9 a to Fig.10 The d in the figure respectively represents the conditions before light irradiation, before drug injection, before photodynamic therapy, and after photodynamic therapy. The horizontal axis is the rotation frequency of the turntable, and the vertical axis is the hearing threshold of the mouse.
[0091] It can be seen that after irradiating the horizontal semicircular canal of mice, injecting Ce6 NPs or performing photodynamic therapy, the hearing threshold of the mice did not change significantly after a period of time, indicating that the function of the adjacent cochlea was not affected, that is, the hearing function of the mice was protected.
[0092] 6. Immunofluorescence staining test
[0093] After the vestibular and hearing function tests mentioned above, the mice in the 10-min light exposure group were dissected and the vestibular semicircular canals, otoliths and cochlear hair cells were obtained and immunofluorescence staining was performed. The specific steps are as follows: First, the inner ear of the mouse on the surgical side was removed for fixation, soaked in 4% paraformaldehyde for 24 hours, and then soaked in EDTA decalcification solution for 48 hours, and the contralateral ear on the surgical side was used as a control. Next, microdissection was performed to obtain the three important tissue parts of the horizontal semicircular canal ampulla ridge, otolith utricle, and cochlear basilar membrane, and these three tissues were immersed in a PBS mixture containing 5% BSA and 1% Triton X-100 for punching. After 1 hour, the tissue was washed three times with PBS, and the primary antibody of Myosin7a diluted 1:500 was added and incubated overnight at 4°C. After removing the tissue, wash it three times with PBS, add 1:200 diluted secondary antibody (Alexa Fluor 488-conjugateddonkey anti-rabbit IgG), dye Phalloidin and dye DAPI, place it on a shaker to avoid light and stain for 1 hour. After staining, wash it three times with PBS and seal it. Finally, take pictures with a confocal microscope and count the survival of hair cells.
[0094] result: Fig.10 Fluorescence microscope images of the ampulla of the horizontal semicircular canal are shown. From top to bottom, they are the group without Ce6 NPs injection and light irradiation, the group without Ce6 NPs injection but light irradiation, the group with Ce6 NPs injection but without light irradiation, and the photodynamic therapy group with Ce6 NPs injection and light irradiation. From left to right, they are the Phalloidin staining results, the Myosin7a antibody staining results, and the fluorescent dye overlay image.
[0095] It can be seen that after local photodynamic therapy, the fluorescence signal emitted by the complex formed by Phalloidin dye and actin filaments in the ampullary crest of the horizontal semicircular canal was significantly weakened, indicating that the actin filaments, as an important component of the cytoskeleton, were damaged to a certain extent, thereby affecting the maintenance of key life activities such as cell morphology, movement and division. In addition, the Myosin7a fluorescence signal was also weakened, that is, the distribution of Myosin7a in the hair cells of the ampullary crest of the horizontal semicircular canal became smaller and the expression level was reduced, indicating that the function of the molecular motor Myosin7a responsible for converting sound waves into neural signals in the hair cells of the inner ear was inhibited to a certain extent. In summary, local photodynamic therapy can significantly damage the hair cells of the ampullary crest of the horizontal semicircular canal of mice.
[0096] Fig.11 and Fig.12 The survival of cells in the otolith utricle is shown. Fig.11Fluorescence microscope images of the otolith utricle. The left and right columns use 100 μm and 50 μm as scales, respectively. From top to bottom, they are the group without Ce6 NPs injection and light irradiation, the group without Ce6 NPs injection but light irradiation, the group with Ce6 NPs injection but no light irradiation, and the photodynamic therapy group with Ce6 NPs injection and light irradiation. Fig.12 a and Fig.12 b in the figure respectively represents the statistical results of the number of hair cells in the peripheral area and the middle area, where both the middle area and the peripheral area are professional terms in the field of inner ear utricle research. The middle area refers to the central area of the inner ear utricle, which is a narrow oval shape and contains structures such as the utricle ridge and the utricle maculae that play an important role in the balance sensory system. The peripheral area refers to the area surrounding the inner ear utricle, which is a wider pear-shaped area and contains structures such as the vestibular nerve and blood vessels.
[0097] It can be seen that the utricle hair cells in the photodynamic group were significantly aggregated and missing, indicating that compared with other groups, after local photodynamic therapy was performed on mice, the utricle hair cells adjacent to the horizontal semicircular canal were damaged and their number decreased significantly. In addition, after 10 minutes of photodynamic therapy, the cells in the middle area were more severely damaged, and the decrease in the number of cells there was more significant than in other groups.
[0098] Fig.13 and Fig.14 Demonstrated the survival of cells in the cochlear basilar membrane, Fig.13 These are fluorescence microscope images of the cochlear basilar membrane. From left to right, they are the group without Ce6 NPs injection and light irradiation, the group with Ce6 NPs injection but without light irradiation, the group without Ce6 NPs injection but with light irradiation, and the photodynamic therapy group with Ce6 NPs injection and light irradiation. From top to bottom, they represent the top, middle, and bottom parts, respectively. Fig.14 This is the statistical result of the number of hair cells at the basilar membrane of the cochlea.
[0099] It can be seen that there is no significant difference in the results of the four groups, and no significant damage was found in the mouse cochlear hair cells after local photodynamic therapy. Therefore, the application of the solution provided in this embodiment will not affect the normal function of the cochlea, and the hearing function can be guaranteed. In actual vestibular-related scientific research and virtual technology development, the range of vestibular hair cell damage can also be adjusted by adjusting parameters such as light power and light time.
[0100] In summary, the present application provides a method for inducing controllable damage to vestibular hair cells in vitro and the application of photosensitizers therein. By utilizing the principle of photodynamic therapy, nanoparticles loaded with photosensitizers are locally delivered to the inner ear, and then the vestibular organ-horizontal semicircular canal is precisely stimulated with a laser to activate the photosensitizer nanoparticles, and reactive oxygen species are produced locally, thereby effectively controlling the range of vestibular organ damage. Without affecting the hearing function, the vestibular receptors-hair cells in the horizontal semicircular canal are damaged, and the vestibular function is significantly inhibited, providing ideas for vestibular research in scientific research fields such as balance, hearing and neurology. In addition, it also provides guidance for improving the sense of reality and interactivity in virtual reality technology.
[0101] The above-described embodiments only express several implementation methods of the present application, which is convenient for understanding the technical solution of the present application in detail, but it cannot be understood as a limitation on the scope of protection of the patent application. It should be pointed out that for ordinary technicians in this field, without departing from the concept of the present application, several deformations and improvements can be made, which all belong to the protection scope of the present application. In addition, it should be understood that after reading the above-mentioned teaching content of the present application, the technicians in this field can make various changes or modifications to the present application, and the equivalent forms obtained also fall within the protection scope of the present application. It should also be understood that the technical solutions obtained by the technicians in this field through logical analysis, reasoning or limited experiments on the basis of the technical solutions provided in the present application are all within the protection scope of the claims attached to the present application. Therefore, the protection scope of the patent of the present application shall be based on the content of the attached claims, and the description and drawings can be used to explain the content of the claims.
Claims
1. An agent for damaging vestibular hair cells, It is characterized in that including a solvent and chlorin e6 and PEG-PLGA added to the solvent; The final concentration of the dihydrochlorin e6 in the solvent is 0.01 mg / mL to 0.02 mg / mL; The final concentration of the PEG-PLGA in the solvent is 0.02 mg / mL to 0.08 mg / mL.
2. The agent for damaging vestibular hair cells according to claim 1, It is characterized in that The solvent includes tetrahydrofuran.
3. A method for constructing a vestibular hair cell injury model. It is characterized in that include: Mixing a reagent for damaging vestibular hair cells with vestibular hair cells to be cultured to prepare a culture; irradiating the culture with light to obtain a vestibular hair cell injury model; The reagent for damaging vestibular hair cells includes a pre-made reagent or a ready-made reagent, and the reagent meets the definition of the reagent for damaging vestibular hair cells as described in any one of claims 1 to 2.
4. The method for constructing a vestibular hair cell injury model according to claim 3, It is characterized in that The method also includes the step of subjecting the reagent for damaging vestibular hair cells to ultrasonic oscillation before mixing.
5. The method for constructing a vestibular hair cell injury model according to claim 3, It is characterized in that The vestibular hair cells are semicircular canal hair cells.
6. The method for constructing a vestibular hair cell injury model according to claim 3, It is characterized in that The light irradiation is performed with a power of 0.4 mW to 0.6 mW for 2 min to 10 min.
7. The method for constructing a vestibular hair cell injury model according to claim 6, It is characterized in that The light irradiation includes irradiation with light in the near infrared region or light in the visible region.
8. The method for constructing a vestibular hair cell injury model according to claim 7, It is characterized in that The wavelength of the light in the near-infrared region is 700nm~1000nm.
9. The method for constructing a vestibular hair cell injury model according to claim 7, It is characterized in that The wavelength of light in the visible light region is 280nm~680nm.
10. The vestibular hair cell damage model constructed by the method for constructing a vestibular hair cell damage model according to any one of claims 3 to 9.
Citation Information
Patent Citations
Nanometer photo-thermal therapy reagent and preparing method thereof
CN105327348A
Application of combined regulation of cell cycle and Atoh1 expression in treatment of vestibular dysfunction
CN117065035A
Application of RAGE inhibitor in preparation of product for preventing or treating hearing impairment
CN117122685A
